Centro Nacional de Epidemiología, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Int J Cancer. 2013 Sep 1;133(5):1164-72. doi: 10.1002/ijc.28102. Epub 2013 Mar 7.
The aim of our study was to determine the baseline prevalence of anal squamous intraepithelial lesions (SIL) and associated risk factors in HIV-infected men who have sex with men (MSM) in a Spanish ongoing multicenter cohort. CoRIS-HPV started in 2007, nested in the Spanish AIDS Research Network Cohort (CoRIS). Anal liquid cytology testing was performed. High-risk human papillomavirus (HR-HPV) infection was determined, and positive samples were genotyped. We analyzed all subjects up to April 2011. Multivariate logistic regression analyses were performed. A total of 551 subjects with baseline anal liquid cytologies were analyzed; 37.0% negative for intraepithelial lesion, 9.0% atypical squamous cells of uncertain significance (ASCUS), 41.0% low-grade SIL, 4.0% high-grade SIL and 9.0% inadequate. Prevalence of anal SIL (excluding ASCUS) in valid samples (n = 450) was 54.7% (95% confidence interval [CI] = 49.9-59.3). Globally HR-HPV prevalence was 81.7% (95% CI = 78.0-85.2). Multiple infections (≥2 HR-HPV genotypes) were documented in 77.7% (95% CI = 73.1-82.0). The only risk factor associated with anal SIL was the number of HR-HPV types; MSM with five or more HR-HPV genotypes had an odds ratio (OR) of anal SIL seven times greater (OR = 7.4; 95% CI = 2.8-19.6) than those with one HR-HPV genotype. No associations were found for age, educational level, smoking, geographical origin, CD4 T-cell count, antiretroviral treatment or number of sexual partners. The prevalence of anal SIL in young HIV-positive MSM is high, and the main risk factor is multiple infections with HR-HPV types.
我们的研究目的是确定在西班牙一个正在进行的多中心队列中,感染 HIV 的男男性行为者(MSM)中肛门鳞状上皮内病变(SIL)的基线患病率以及相关的危险因素。CoRIS-HPV 于 2007 年开始,嵌套在西班牙艾滋病研究网络队列(CoRIS)中。进行了肛门液基细胞学检查。确定高危型人乳头瘤病毒(HR-HPV)感染,并对阳性样本进行基因分型。我们分析了截至 2011 年 4 月的所有受试者。进行了多变量逻辑回归分析。共分析了 551 例基线肛门液基细胞学检查的受试者;37.0%的上皮内病变阴性,9.0%的非典型鳞状细胞意义不明确(ASCUS),41.0%的低级别 SIL,4.0%的高级别 SIL 和 9.0%的不充分。在有效的样本(n=450)中,肛门 SIL(不包括 ASCUS)的患病率为 54.7%(95%置信区间 [CI]:49.9-59.3)。全球 HR-HPV 患病率为 81.7%(95% CI:78.0-85.2)。记录了 77.7%(95% CI:73.1-82.0)的多重感染(≥2 种 HR-HPV 基因型)。唯一与肛门 SIL 相关的危险因素是 HR-HPV 类型的数量;与只有一种 HR-HPV 基因型的 MSM 相比,有五种或更多 HR-HPV 基因型的 MSM 肛门 SIL 的优势比(OR)高 7 倍(OR=7.4;95% CI:2.8-19.6)。未发现年龄、教育水平、吸烟、原籍地、CD4 T 细胞计数、抗逆转录病毒治疗或性伴侣数量与肛门 SIL 相关。年轻 HIV 阳性 MSM 中肛门 SIL 的患病率较高,主要危险因素是 HR-HPV 类型的多重感染。